US Stem Cell Inc (USRM)

[fast.money]

This company has been around for a while! This company has a Founded in 1999, Bioheart, Inc. is committed to the development of effective cell technologies to treat cardiovascular diseases. Bioheart’s discoveries include multiple cell therapies in various stages of development that repair damaged hearts of patients suffering from chronic and acute heart damage.

Bioheart’s goals are to cause damaged tissue to be regenerated, when possible, improve a patient's quality of life and reduce overall health care costs and hospitalizations. Bioheart’s lead product candidate is MyoCell®, currently in Phase III trials, a muscle stem cell therapy that is intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack.